Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

2016 ◽  
Author(s):  
Daniel Vorobiof
Keyword(s):  
Breast Cancer ◽  
Oestrogen Receptor ◽  
Randomised Trial ◽  
Adjuvant Tamoxifen ◽  
Long Term Effects ◽  
Positive Breast Cancer

scholarly journals Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer

2013 ◽  
Vol 49 (6) ◽  
pp. 1196-1204 ◽  
Author(s):  
Helena Fohlin ◽  
Gizeh Pérez-Tenorio ◽  
Tommy Fornander ◽  
Lambert Skoog ◽  
Bo Nordenskjöld ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Oestrogen Receptor ◽  
Long Term Prognosis ◽  
Positive Breast Cancer

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 5-5 ◽  
Author(s):  
Richard G. Gray ◽  
Daniel Rea ◽  
Kelly Handley ◽  
Sarah Jane Bowden ◽  
Philip Perry ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Early Breast Cancer ◽  
Adjuvant Tamoxifen ◽  
Long Term Effects ◽  
Daily News ◽  
Online Supplement ◽  
Final Text

5 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Sunday, June, 2, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Sunday edition of ASCO Daily News.

Sign in / Sign up

Export Citation Format

Share Document